Skip to Content
  • 3.5
    Impact Factor
  • 5.1
    CiteScore
  • 28 days
    Submission to First Decision
  • 3 days
    Acceptance to Publication

Pathophysiology

Pathophysiology is an international, peer-reviewed, open access journal on the etiology, development, and elimination of pathological processes, published quarterly online by MDPI (since Volume 21, Issue 1 - 2020). The International Society for Pathophysiology (ISP) is affiliated with Pathophysiology, serving as its official journal. Society members receive discounts on the article processing charges.
  • Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
  • High Visibility: indexed within ESCI (Web of Science), Scopus, PMC, PubMed, and other databases.
  • Journal Rank: JCR - Q1 (Pathology) / CiteScore - Q1 (Pathology and Forensic Medicine)
  • Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 27.7 days after submission; acceptance to publication is undertaken in 2.9 days (median values for papers published in this journal in the first half of 2026).
  • Recognition of Reviewers: Reviewers whose reports are timely and of high quality receive an APC discount voucher for a future publication in an MDPI journal. Become a reviewer.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (346)

  • Article
  • Open Access

Background: Lipid nanoparticles (LNPs) can activate innate immunity, but the factors shaping repeat-dose reactogenicity remain unclear. We compared systemic, local, and organ-specific reactions after intramuscular administrations of empty LNPs containing ionizable lipids used in mRNA vaccines. Methods: Female BALB/c mice received two intramuscular injections, 2 weeks apart, of LNP-4 (four components, ALC-0315 as the sole ionizable lipid; 59 nm) or LNP-5 (five components, equimolar ALC-0315/SM-102 at the same total ionizable lipid content; 86 nm). Body weight was monitored for 15 days. Blood biochemical parameters, injection-site histology, and morphological and molecular markers in the hypothalamus, liver, lungs, and spleen were assessed 24 h after the second injection by histology, immunohistochemistry (IHC), immunofluorescence (IF), Western blotting, and quantitative PCR (qPCR). Results: Both LNPs were followed by transient body-weight loss, moderate biochemical changes, and local reactogenicity. The strongest organ-specific responses occurred in the liver and hypothalamus. Both LNPs induced hepatic sinusoidal dilation and leukocyte infiltration, but LNP-4 was associated with more myeloid cell numbers and higher inflammatory marker expression. In the hypothalamus, LNP-4 produced broader changes in inflammatory and myeloid marker expression than LNP-5. No marked structural damage was observed in the examined organs. Conclusions: Repeated LNP administration was followed by systemic and local reactogenicity, and organ-specific changes differed between the formulations, possibly reflecting lipid composition, particle size, and lipid dose. Carrier composition should be considered in the design and safety evaluation of LNP-based vaccine delivery systems.

Pathophysiology

28 October 2026

Experimental design and analytical workflow for the assessment of empty LNP-4 and LNP-5.
  • Article
  • Open Access

Background: The functional state of skeletal muscle is governed by the interaction of mechanical loading, neural control, and proprioceptive afferentation. Nonetheless, the relative impact of the disruption of these components on muscle function and structure remains insufficiently characterized. Methods: In the present study, we investigated three rat models of muscle disuse and two combined models: hindlimb unloading (n = 40), denervation (D, n = 40), tenotomy (T, n = 40), and the combinations HU + D (n = 8) and HU + T (n = 8), with the cumulative effects evaluated at 7, 14, 35, and 50 days. Functional changes were assessed using electrophysiological methods (M-response recording), and structural changes were evaluated by histological, immunohistochemical, and immunofluorescence analysis. Results: The disuse models elicited significantly distinct trajectories of muscle maladaptation. Hindlimb unloading induced coordinated functional and structural remodeling; denervation provoked early functional decline followed by structural changes; tenotomy largely preserved functional activity despite progressive structural remodeling. The combination of denervation with unloading partially attenuated the negative effects, whereas the combination of unloading and tenotomy led to functional enhancement in some cases. These findings provide insight into the degree of convergence, additivity, and synergy of the disruption of regulatory components and indicate that reduced electrical activity is not invariably associated with synchronous structural degradation, revealing a functional–structural dissociation wherein functional status fails to reflect structural integrity. Conclusions: This observation suggests a previously unrecognized mechanism of maladaptation, which diverges from classical atrophy, broadening our understanding of muscle disuse physiology and offering new perspectives for the development of preventive and therapeutic strategies against atrophic processes.

Pathophysiology

28 October 2026

Experimental design. Experimental groups and time points of functional and structural assessments: at baseline (before intervention) and at days 7, 14, 35, and 50. HU = hindlimb unloading.
  • Review
  • Open Access

Modeling Nontuberculous Mycobacterial Disease in Xenopus laevis

  • Shelby Peres,
  • Martin S. Pavelka and
  • Jacques Robert

The global incidence of diseases caused by Mycobacterium abscessus (Mab), which is a nontuberculous mycobacterium (NTM), is increasing, driven by improved diagnostics and environmental changes that disrupt natural reservoirs in soil and water. These disruptions facilitate contamination of water systems. Immunocompromised individuals, particularly those with cystic fibrosis or chronic obstructive pulmonary disease, are at elevated risk, although Mab can also infect otherwise healthy individuals, causing pulmonary and cutaneous disease. Clinical management remains challenging due to intrinsic antibiotic resistance and the limited efficacy of standard anti-tuberculosis regimens. Despite this growing burden, the mechanisms governing Mab persistence and pathogenesis remain poorly defined. Progress has been constrained by the limitations of existing animal models. Mice typically clear infections rapidly, even when immunocompromised, limiting studies of chronic disease. Zebrafish support persistent infection but lack lungs and have a less developed adaptive immune system. These limitations highlight the need for alternative models. Here, we present a perspective highlighting the amphibian Xenopus laevis as a complementary model for investigating Mab chronic infection and disease. X. laevis tadpoles develop functional lungs early and possess conserved innate and adaptive immune components, including macrophages and antigen presentation pathways. Their external development allows precise control of environmental exposures and accessibility to experimentation, such as live imaging, to study Mab infection over 50 days. Xenopus models combine the experimental accessibility of early developmental stages, genetic and transgenic tractability, and established protocols for animal husbandry and mycobacterial that are characteristic of zebrafish, with the conserved lung architecture of mammals. We discuss the application of Xenopus models to investigate the potential role of a novel putative secondary metabolite gene cluster (SMGC) hypothesized to encode a virulence factor that promotes Mab colonization, interaction with macrophages, and persistence. Collectively, these features establish X. laevis tadpoles as a valuable experimental platform for dissecting host–pathogen interactions and for identifying potential targets for therapeutic intervention.

Pathophysiology

28 October 2026

Schematic map of SMGC in Mab. The ORFs are numbered according to the ATCC19977 strain. Mab genes 0284c to 0290 and 0295 to 0298 are syntenic with streptonigrin genes of Streptomyces species, with the latter gene block flipped in Mab. Boxed in green is cdaR, which encodes a putative transcriptional activator for the cluster and boxed in red is the phzC gene targeted for deletion. In purple are genes unique to the Mab cluster carboxyesterase type B (0294); NbaD aminocarboxymuconate-semialdehyde decarboxylase (0299).
  • Article
  • Open Access

Background/Objectives: Mild traumatic brain injury (mTBI) can cause persistent neuroinflammation and astroglial reactivity. This study examined whether peri-injury administration of stearidonic acid ethanolamide (SDEA) was associated with changes in astrocyte-associated responses after mTBI and in primary astroglial cultures. Methods: Male C57BL/6 mice received SDEA (10 mg/kg, subcutaneously) for 2 days before mTBI, immediately after injury, and for 7 days thereafter. At 11 weeks post-injury, cortical GFAP immunoreactivity and the expression of astrocyte-associated markers, PPAR isoforms, and neurotrophic factors were assessed by immunohistochemistry and RT-qPCR. Primary astroglial cultures were treated with 1 or 10 μM SDEA for 48 h. Results: SDEA attenuated mTBI-associated increases in GFAP-positive cells and cortical Gfap and C3 expression while increasing S100a10 and Clcf1 expression. SDEA treatment was accompanied by increased cortical Ppara and Pparg mRNA expression and changes in the expression of neurotrophic-factor genes. In cultured astroglia, SDEA increased S100a10, Clcf1, Ppara, Pparg, Bdnf, Ngf, and Gdnf mRNA expression without significantly altering Gfap or C3. Conclusions: Peri-injury SDEA administration was associated with reduced chronic cortical GFAP reactivity and changes in selected astrocyte-associated transcripts after mTBI.

Pathophysiology

20 October 2026

Experimental design. (A) Allocation of 44 mice to four experimental groups (n = 11 animals per group) and schedule of SDEA administration. At 11 weeks after injury, seven animals per group were used for immunohistochemistry and four animals per group were used for cortical RT-qPCR. (B) Procedure used to induce mTBI. (C) Cortical tissue sampling for immunohistochemical and molecular analyses. This figure presents the experimental design and does not contain quantitative comparisons.

Featured Articles of Last Quarter

Raincloud plot of HF-HRV values across experimental conditions. Individual data points are shown for the two experimental conditions (resting and heartbeat). Boxplots represent the distribution of the data, and shaded areas represent the data density. * indicates a statistically significant difference between conditions (p < 0.05).

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Pathophysiology - ISSN 1873-149X